Hey George, hope it blast's off for you and others that are in. Mars posted this info this morn from Cowen, hope their not dumping into a pump. Looks so Very much undervalued... and my reason for jumping in. Sure needs more push , keeping fingers crossed ! GLTY
Cowen & Co expects most of their earnings-driven Biotech companies to post strong Q2 results
Cowen & Co expects most of their earnings-driven Biotech companies to post strong Q2 results. Firm's favorite names to beat consensus include AMGN, BIIB, CEPH, DNA, GILD, ILMN and VPHM. They think results for GENZ, ICOS, IMCL, MEDI and UTHR should be at least in line with expectations. They also believe some caution is warranted on Q2 expectations for CIPH, CVTX, NTMD, and TRCA. In addition, firm says the life sciences/tools sector continues to be touch and go. Firm's analysis of prior biotech bear markets indicates that larger, earnings-driven companies typically outperform during tough times and usually lead the sector during the early days of a rally.
"Kind words can be short and easy to speak but their echoes are truly endless" "What lies behind us and what lies before us are small matters compared to what lies within us"